Michelle Arkin

Michelle Arkin co-founded Ambagon Therapeutics and Elgia Therapeutics, Inc. Michelle is currently a Professor of Pharmaceutical Chemistry at the University of California, San Francisco, where Michelle also serves as the Executive Director. Prior to their current roles, Michelle was an Associate Professor at Sunesis Pharmaceuticals and a Damon Runyon Postdoctoral Fellow at Genentech. Michelle completed their BA in Chemistry and History of Art at Bryn Mawr College and received their PhD in Chemistry from the California Institute of Technology. Their expertise lies in small molecule screening, fragment discovery, and drug-discovery technology.